Search Results - "Rubio Herrera, M.Á."

Endoscopic argon plasma coagulation (APC) vs glucagon-like peptide-1 receptor agonists (ARGLP1) liraglutide and semaglutide for the treatment of weight regain (WR) after bariatric surgery (BS) by Mera Carreiro, S., Bernaldo Madrid, B., Rodríguez Carrillo, C., Matía Martín, P., Pérez Ferre, N., Marcuello Foncillas, C., Espinosa de los Monteros Sicilia, P., Ramos Levi, A., Esteban Lopez-Jamar, J.M., Rubio Herrera, M.Á.

Get full text

Tratamiento farmacológico de la obesidad para médicos de Atención Primaria by Rubio Herrera, M.A, Fernández-García, J.M, Corio Andújar, R, Santos Altozano, C, Urieta Carpi, J.J

“…ResumenLa obesidad es una enfermedad de alta prevalencia en las consultas de Atención Primaria. Se asocia a comorbilidades mayores (dislipidemia, diabetes,…”
Get full text

Check-ups in obese and diabetic patients: preventive medicine by Charro Salgado, A.L, Rubio Herrera, M.A, Runkle de la Vega, D.J

“…Obesity is a chronic disease associated with important additional diseases, such as DM 2, that both reduce life quality and increase morbimortality from any…”
Get full text

Costs resulting from premature mortality due to cardiovascular causes: A 20-year follow-up of the DRECE study by Gómez-de la Cámara, A., Pinilla-Domínguez, P., Vázquez-Fernández del Pozo, S., García-Pérez, L., Rubio-Herrera, M.A., Gómez-Gerique, J.A., Gutiérrez-Fuentes, J.A., Rivero-Cuadrado, A., Serrano-Aguilar, P.

“…Cardiovascular diseases are still the leading cause of death in Spain. The DRECE study (Diet and Cardiovascular Disease Risk in Spain), based on a…”
Get full text